Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

A systematically combined genotype and functional combination analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in different geographic areas of mainland China--a basis for personalized therapy.

Wu Z, Zhang X, Shen L, Xiong Y, Wu X, Huo R, Wei Z, Cai L, Qi G, Xu Q, Cui D, Cui D, Zhao G, He L, Qin S.

PLoS One. 2013 Oct 2;8(10):e71934. doi: 10.1371/journal.pone.0071934. eCollection 2013.

2.

Frequencies of genotypes and alleles of the functional SNPs in CYP2C19 and CYP2E1 in mainland Chinese Kazakh, Uygur and Han populations.

Wang SM, Zhu AP, Li D, Wang Z, Zhang P, Zhang GL.

J Hum Genet. 2009 Jun;54(6):372-5. doi: 10.1038/jhg.2009.41. Epub 2009 May 15.

PMID:
19444287
3.

Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations.

Yin SJ, Ni YB, Wang SM, Wang X, Lou YQ, Zhang GL.

J Clin Pharm Ther. 2012 Jun;37(3):364-9. doi: 10.1111/j.1365-2710.2011.01298.x. Epub 2011 Sep 14.

PMID:
21913948
5.

CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.

Scott SA, Edelmann L, Kornreich R, Erazo M, Desnick RJ.

Pharmacogenomics. 2007 Jul;8(7):721-30. doi: 10.2217/14622416.8.7.721.

PMID:
18240905
6.

Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales.

Sistonen J, Fuselli S, Palo JU, Chauhan N, Padh H, Sajantila A.

Pharmacogenet Genomics. 2009 Feb;19(2):170-9. doi: 10.1097/FPC.0b013e32831ebb30.

PMID:
19151603
7.

Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia.

Griese EU, Ilett KF, Kitteringham NR, Eichelbaum M, Powell H, Spargo RM, LeSouef PN, Musk AW, Minchin RF.

Pharmacogenetics. 2001 Feb;11(1):69-76.

PMID:
11207032
8.

Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.

Arvanitidis K, Ragia G, Iordanidou M, Kyriaki S, Xanthi A, Tavridou A, Manolopoulos VG.

Fundam Clin Pharmacol. 2007 Aug;21(4):419-26.

PMID:
17635181
9.

Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China.

Chen L, Qin S, Xie J, Tang J, Yang L, Shen W, Zhao X, Du J, He G, Feng G, He L, Xing Q.

Pharmacogenomics. 2008 Jun;9(6):691-702. doi: 10.2217/14622416.9.6.691.

PMID:
18518848
10.

Cytochrome p450 polymorphisms in geriatric patients: impact on adverse drug reactions--a pilot study.

Egger T, Dormann H, Ahne G, Pahl A, Runge U, Azaz-Livshits T, Neubert A, Criegee-Rieck M, Gassmann KG, Brune K.

Drugs Aging. 2005;22(3):265-72.

PMID:
15813658
11.

Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.

Hamdy SI, Hiratsuka M, Narahara K, El-Enany M, Moursi N, Ahmed MS, Mizugaki M.

Br J Clin Pharmacol. 2002 Jun;53(6):596-603.

12.

Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping of CYP2C9, CYP2C19 and CYP2D6 genes.

Villagra D, Goethe J, Schwartz HI, Szarek B, Kocherla M, Gorowski K, Windemuth A, Ruaño G.

Biomark Med. 2011 Aug;5(4):427-38. doi: 10.2217/bmm.11.32.

13.

Correlation of genotype, phenotype, and mRNA expression of CYP2D6 and CYP2C19 in peripheral blood leukocytes (PBLs).

Kuhlmann JB, Wensing G, Kuhlmann J.

Int J Clin Pharmacol Ther. 2014 Feb;52(2):143-50. doi: 10.5414/CP201966.

PMID:
24361088
14.

Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.

Bozina N, Granić P, Lalić Z, Tramisak I, Lovrić M, Stavljenić-Rukavina A.

Croat Med J. 2003 Aug;44(4):425-8.

15.

Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.

Halling J, Petersen MS, Damkier P, Nielsen F, Grandjean P, Weihe P, Lundgren S, Lundblad MS, Brøsen K.

Eur J Clin Pharmacol. 2005 Aug;61(7):491-7. Epub 2005 Jul 16.

PMID:
16025294
16.

The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liver.

Coller JK, Krebsfaenger N, Klein K, Endrizzi K, Wolbold R, Lang T, Nüssler A, Neuhaus P, Zanger UM, Eichelbaum M, Mürdter TE.

Br J Clin Pharmacol. 2002 Aug;54(2):157-67.

17.

Genotyping of cytochrome p450 isoform genes is useful for forensic identification of cadaver.

Ogawa K, Suno M, Shimizu K, Yoshida M, Awaya T, Matsubara K, Shiono H.

Leg Med (Tokyo). 2003 Sep;5(3):132-8.

PMID:
14568772
18.

The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.

de Leon J, Susce MT, Murray-Carmichael E.

Mol Diagn Ther. 2006;10(3):135-51. Review.

PMID:
16771600
19.

Determination of CYP2D6, CYP2C9 and CYP2C19 genotypes with Tag-It mutation detection assays.

Melis R, Lyon E, McMillin GA.

Expert Rev Mol Diagn. 2006 Nov;6(6):811-20.

PMID:
17140368
20.

Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.

Veiga MI, Asimus S, Ferreira PE, Martins JP, Cavaco I, Ribeiro V, Hai TN, Petzold MG, Björkman A, Ashton M, Gil JP.

Eur J Clin Pharmacol. 2009 Apr;65(4):355-63. doi: 10.1007/s00228-008-0573-8. Epub 2008 Nov 1.

PMID:
18979093
Items per page

Supplemental Content

Write to the Help Desk